Phase Ib trial of varlitinib plus weekly paclitaxel in EGFR/HER2 co-expressing advanced gastric cancer (AGC)

Sang, Y; Jung, M; Kim, HS; Kang, B; Lee, CK; Chung, HC; Rha, SY

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (3):